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Global impact of musculoskeletal disorders
The World Health Organization (WHO) has identified the
four most lethal, noncommunicable diseases affecting the
greatest proportion of the world population as cardiovas-
cular diseases, cancer, respiratory diseases, and diabetes.
While musculoskeletal (MSK) conditions are the second
greatest cause of disability and account for one-third of all
work sick leave [1], the WHO does not place the same
awareness on MSK conditions. Greater awareness of dis-
eases maintains visibility, which leads to greater funding for
research and education, making it more difficult for the
under-recognised diseases to gain the necessary resources
to make an impact in the field [2].
It is thus imperative for MSK interest groups to appeal
to not only the WHO, but also governments, pharmaceu-
tical companies, and regulatory bodies to give greater
attention to MSK conditions. For instance, the Bone and
Joint Decade (BJD) has contributed to the WHO Global
Disability Action Plan, which is a systematic review similar
to that of the highlighted noncommunicable diseases. The
BJD has also contributed to the WHO report on ageing and
health, which will be followed by an action plan [3]. While
BJD has done an excellent job in promoting global
awareness of MSK conditions, especially with larger or-
ganisations, the question about how advantageous this is
for individual institutions in making a translational dif-
ference remains controversial. For this reason, smaller
groups who are able to establish in-depth discussions and
co-ordinate themselves around a centralised goal are
essential.
Some organisations are already recognising this need to
support the study of numerous diseases. Horizon 2020 is the
largest European Union Research and Innovation pro-
gramme, with explicit recognition of MSK conditions. This
programme not only funds orthopaedic projects, but en-
courages cross-disciplinary research, thus allowing for a
disease to be holistically studied and treated [4,5], and
access to such grants will be greater achieved by groups
focused on one goal with multiple fields of expertise.
162 EditorialBackground and launch
The Musculoskeletal Regeneration Research Network (MRN)
is an international consortium to promote MSK regeneration
and translational research to encourage collaboration to
enhance achievement. It was inaugurated on November 13,
2013 during the 3rd International Symposium of Stem Cell
Biology and Regenerative Medicine (SCRM) (Appendix 1).
With the vision to advocate a strong voice in the field of
MSK regenerative research and a collective opinion leader
in the field, the MRN is an ideal platform to establish a
taskforce to translate the research conducted by partici-
pating members into clinical practice. By building a strong
network with like-minded teams and institutions, members
of this network will gain unique opportunities to enhance
their research and clinical practice and outcomes, as well
as enabling assistance in applying for grants, through their
MRN collaborations. The MRN will also be able to form
active relationships with industries, to bring academic
research into the clinical realm. Ultimately, such in-
teractions will lead to effective knowledge transfer
amongst the MRN members, to ensure projects remain on
track and achieve their ultimate goals.
The missions of the MRN are to (1) establish an effective,
collaborative platform to facilitate MSK regenerative
research; (2) bridge the gap in translation in MSK regener-
ative research between professional bodies and industries;
(3) enhance the academic and professional output of
members of the network; and (4) host high-quality meet-
ings in strategic global sites to promulgate the impact of
MSK regenerative research.
MRN: progress update
Based on the Fragility Fracture Network model [6], the MRN
aims at bringing together like-minded researchers from
global institutions, focusing on MSK regeneration and
turning basic science into translatable results. In the past 5
years, the MRN has taken the necessary steps to build a firm
foundation and expand to include illustrious institutions,
allowing access to new grants, publication of more
research, and providing staff and students the opportunity
to learn and share expertise and knowledge beneficial to
both the host and home institutions [7]. For example, the
collaboration between The Chinese University of Hong Kong
(CUHK) and Karolinska Institute (KI) has already achieved
numerous benefits. KI has access to a large number of
human tendinopathy samples for the analysis of microbial
presence, while CUHK has cell-culture facilities to study the
pathogenesis of microbes on the development of tendin-
opathy. The project has expanded its collaborative efforts
to Uppsala University, by virtue of its bioinformatics facil-
ities. Furthermore, the collaborating institutions were
approached by the University Hospital of Trondheim, Nor-
way, supplying additional tendinopathy samples to increase
sample and demographic size in the study. A similarcollaborative platform has been established between CUHK
and University Medical Centre Utrecht. University Medical
Centre Utrecht has developed hydrogel three-dimensional
printing technology for regeneration of focal chondral de-
fects, while CUHK is working on injectable products to treat
degenerative osteoarthritis, with a shared interest in
developing value-added biomaterials for these applica-
tions. Recently, CUHK researchers visited the University of
Southern Denmark, and held a joint symposium on MSK
regeneration. A formal Memorandum of Understanding
(MOU) has been signed and a project is being planned for
the development of bioactive constructs, wherein both in-
stitutions will apply for research grants, establish a joint
PhD programme, and share resources and facilities. Dele-
gates from CUHK recently visited Stanford University, CA,
USA (Stanford delegates have previously visited CUHK),
under the auspices of a signed MOU between the two in-
stitutions, to initiate lectures and formulate new research
bonds in various MSK fields. A similar, research-focused
MOU is also in place between the University of Pittsburgh,
PA, USA and CUHK. In addition, opportunities for collabo-
ration in research, education, grants, and publication in
both academia and industry are also being developed. Re-
searchers from the AO Foundation, Shanghai Jiao Tong
University, and CUHK have formed the European and Chi-
nese RAPIDOS consortium, to collaborate on the project
titled “rapid prototyping of custom-made bone-forming
tissue engineering constructs,” which received funding
from the European Commission and the National Natural
Science Foundation of China in 2013 [8]. Furthermore, the
collaboration between Shanghai Jiao Tong University and
CUHK has produced another study on tendinopathy and
tendon regeneration, which has resulted in the sharing of
resources and facilities, education opportunities, and a
number of publications [9e11]. Further collaboration is also
under development with Brown University and CUHK, in
which a publication studying stromal-cell-derived factor-1
and osteoarthritis has been published [12], as well as
facilitating scholars and students from CUHK to visit Brown
University.
Through this growing network of international collab-
orators and promising research opportunities, the 1st In-
ternational Symposium of Musculoskeletal Regeneration
Research Network (MRN) (Appendix 1) was held at KI on
June 1e2, 2015. The programme timetable is shown in
Appendix 2. The aim of the symposium was to encourage
member institutions to share recent work, as well as
discuss and develop future research opportunities and
collaborations, such as acute and chronic inflammation
and infection in MSK disease, and tissue regeneration. The
participants also discussed how MRN can move forward to
accomplish its goals. It is believed that the MRN not only
presents opportunities for collaborative ventures amongst
similar institutions, but also enables collaboration with
pharmaceutical and governmental regulatory bodies to
implement systems towards effective translational
Editorial 163activities. The Albert Einstein College of Medicine
expressed their excitement for recently joining MRN,
emphasising specifically the opportunity of interaction
with other international institutions and potential col-
laborations with other members of the MRN. Following the
success of the first MRN meeting, annual meetings are
planned for 2016 (Utrecht, The Netherlands) and 2017
(Davos, Switzerland).
The MRN holds a unique position in that it has a diverse
group of members who have specialised knowledge, sys-
tems, and facilities in place, to bring research from bench-
to-bedside. The MRN has the advantage of maintaining a
small, tight-knit community to maintain specific, focusedAppendix 1 Musculoskeletal Regeneration Researc
Figure 1 Stem Cell Biology and Regenerative Medicine and Muscu
Annual International Symposium on Stem Cell Biology and Regener
skeletal Regeneration Research Network, 13 November 2013; and (C
Research Network, 1e2 June 2015.discussions and allowing stronger, effective collaborations.
Such collaborations have already shown significant mutual
benefits for both MSK investigators and their institutions.
The overall outcome of greater access to facilities,
knowledge, resources, grants, publications, and technol-
ogy, enabled by the MRN, will bring about substantive ad-
vancements in making bench-to-bedside translational
research a reality.Conflicts of interest
All authors declare no conflicts of interest.h Network group
loskeletal Regeneration Research Network key events: (A) Third
ative Medicine, 11e12 November 2013; (B) launch of Musculo-
) 1st International Symposium on Musculoskeletal Regeneration
Appendix 2 Musculoskeletal Regeneration Research Network meeting programme
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